Caricamento...

Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer

KRAS is frequently mutated in a variety of cancers including lung cancer. Whereas the mitogen-activated protein kinase (MAPK) is a well-known effector pathway of KRAS, blocking this pathway with MEK inhibitors is relatively ineffective. One major contributor to limited efficacy is attributed to the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Small GTPases
Autori principali: Kitai, Hidenori, Ebi, Hiromichi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584737/
https://ncbi.nlm.nih.gov/pubmed/27392325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21541248.2016.1210369
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !